Le Lézard
Classified in: Health
Subjects: CCA, FVT

Bausch Health Companies Will Release Second-Quarter 2018 Financial Results On August 7


LAVAL, Quebec, July 18, 2018 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its second-quarter 2018 financial results on Tuesday, Aug. 7, 2018. Bausch Health will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Bausch Health web site prior to the start of the call.

Conference Call Details


Date:

Tuesday, Aug. 7, 2018

Time:

8:00 a.m. EDT

Webcast:

http://ir.bauschhealth.com/events-and-presentations

Participant Event Dial-in: 

(844) 428-3520 (North America)


(409) 767-8386 (International) 

Participant Passcode:

1378128

Replay Dial-in:

(855) 859-2056 (North America)


(404) 537-3406 (International) 

Replay Passcode:

1378128 (replay available until Oct. 7, 2018)

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

[email protected]

[email protected]

(514) 856-3855

(908) 927-0617

(877) 281-6642 (toll free)


 

 

SOURCE Bausch Health Companies Inc.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: